Related references
Note: Only part of the references are listed.MicroRNA-214-5p involves in the protection effect of Dexmedetomidine against neurological injury in Alzheimer's disease via targeting the suppressor of zest 12
Guangjun Hu et al.
BRAIN RESEARCH BULLETIN (2022)
MicroRNA let-7 and viral infections: focus on mechanisms of action
Arash Letafati et al.
CELLULAR & MOLECULAR BIOLOGY LETTERS (2022)
Dexmedetomidine exerts cerebral protective effects against cerebral ischemic injury by promoting the polarization of M2 microglia via the Nrf2/HO-1/NLRP3 pathway
Ning Wang et al.
INFLAMMATION RESEARCH (2022)
Peptidylarginine deiminase 2 promotes T helper 17-like T cell activation and activated T cell-autonomous death (ACAD) through an endoplasmic reticulum stress and autophagy coupling mechanism
Yi-Fang Yang et al.
CELLULAR & MOLECULAR BIOLOGY LETTERS (2022)
Protective effects of dexmedetomidine on small intestinal ischaemia-reperfusion injury in horses
Ashley R. VanderBroek et al.
EQUINE VETERINARY JOURNAL (2021)
Dexmedetomidine post-conditioning ameliorates long-term neurological outcomes after neonatal hypoxic ischemia: The role of autophagy
Hang Xue et al.
LIFE SCIENCES (2021)
The potential role of dexmedetomidine on neuroprotection and its possible mechanisms: Evidence from in vitro and in vivo studies
Kantarakorn Unchiti et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2021)
Dexmedetomidine alleviates hepatic ischaemia-reperfusion injury via the PI3K/AKT/Nrf2-NLRP3 pathway
Yan Wu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)
Crosstalk between miRNA and PI3K/AKT/mTOR signaling pathway in cancer
Maryam Akbarzadeh et al.
LIFE SCIENCES (2021)
lncRNA C2dat2 facilitates autophagy and apoptosis via the miR-30d-5p/DDIT4/mTOR axis in cerebral ischemia-reperfusion injury
Qian Xu et al.
AGING-US (2021)
Dexmedetomidine Attenuates Lung Injury in Toxic Shock Rats by Inhibiting Inflammation and Autophagy
Zhi-Bing Li et al.
ARCHIVES OF MEDICAL RESEARCH (2021)
Cancer cells escape autophagy inhibition via NRF2-induced macropinocytosis
Hua Su et al.
CANCER CELL (2021)
The Protective Mechanism of Dexmedetomidine in Regulating Atg14L-Beclin1-Vps34 Complex Against Myocardial Ischemia-Reperfusion Injury
Yanna Li et al.
JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH (2021)
Dexmedetomidine Protects Against Septic Liver Injury by Enhancing Autophagy Through Activation of the AMPK/SIRT1 Signaling Pathway
Qing Yu et al.
FRONTIERS IN PHARMACOLOGY (2021)
Dexmedetomidine ameliorates endotoxin-induced acute lung injury in vivo and in vitro by preserving mitochondrial dynamic equilibrium through the HIF-1a/HO-1 signaling pathway
Jia Shi et al.
REDOX BIOLOGY (2021)
Autophagy receptors as viral targets
Paivi Yla-Anttila
CELLULAR & MOLECULAR BIOLOGY LETTERS (2021)
Dexmedetomidine attenuates neuronal injury induced by cerebral ischemia-reperfusion by regulating miR-199a
Yulin Zhu et al.
MOLECULAR MEDICINE REPORTS (2021)
Dexmedetomidine alleviates early brain injury following traumatic brain injury by inhibiting autophagy and neuroinflammation through the ROS/Nrf2 signaling pathway
Xiaoyan Feng et al.
MOLECULAR MEDICINE REPORTS (2021)
Insulin-like growth factor 1 promotes neurological functional recovery after spinal cord injury through inhibition of autophagy via the PI3K/Akt/mTOR signaling pathway
Duo Zhang et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2021)
Dexmedetomidine Protects Human Cardiomyocytes Against Ischemia-Reperfusion Injury Through α2-Adrenergic Receptor/AMPK-Dependent Autophagy
Yingying Xiao et al.
FRONTIERS IN PHARMACOLOGY (2021)
Ginsenoside Rb1 Inhibits Cardiomyocyte Autophagy via PI3K/Akt/mTOR Signaling Pathway and Reduces Myocardial Ischemia/Reperfusion Injury
Guo-Wei Qin et al.
AMERICAN JOURNAL OF CHINESE MEDICINE (2021)
Dexmedetomidine Protects Against Oxygen-Glucose Deprivation-Induced Injury Through Inducing Astrocytes Autophagy via TSC2/mTOR Pathway
Chen Zhu et al.
NEUROMOLECULAR MEDICINE (2020)
Ferrostatin-1 alleviates lipopolysaccharide-induced acute lung injury via inhibiting ferroptosis
Pengfei Liu et al.
CELLULAR & MOLECULAR BIOLOGY LETTERS (2020)
Dexmedetomidine postconditioning suppresses myocardial ischemia/reperfusion injury by activating the SIRT1/mTOR axis
Xiong Zhang et al.
BIOSCIENCE REPORTS (2020)
Basic Mechanisms of Diabetic Heart Disease
Rebecca H. Ritchie et al.
CIRCULATION RESEARCH (2020)
Dexmedetomidine Protects Against Lipopolysaccharide-Induced Acute Kidney Injury by Enhancing Autophagy Through Inhibition of the PI3K/AKT/mTOR Pathway
Yuan Zhao et al.
FRONTIERS IN PHARMACOLOGY (2020)
Dexmedetomidine Improves Cardiovascular and Ventilatory Outcomes in Critically Ill Patients: Basic and Clinical Approaches
Rodrigo L. Castillo et al.
FRONTIERS IN PHARMACOLOGY (2020)
Dexmedetomidine protects against acute kidney injury in patients with septic shock
Jingquan Liu et al.
ANNALS OF PALLIATIVE MEDICINE (2020)
Dexmedetomidine Enhances Autophagy via α2-AR/AMPK/mTOR Pathway to Inhibit the Activation of NLRP3 Inflammasome and Subsequently Alleviates Lipopolysaccharide-Induced Acute Kidney Injury
Tianyuan Yang et al.
FRONTIERS IN PHARMACOLOGY (2020)
Neuroprotective Effects of Dexmedetomidine Preconditioning on Oxygen-glucose Deprivation-reoxygenation Injury in PC12 Cells via Regulation of Ca2+-STIM1/Orai1 Signaling
Yi-da Hu et al.
CURRENT MEDICAL SCIENCE (2020)
Dexmedetomidine inhibits inflammatory response and autophagy through the circLrp1b/miR-27a-3p/Dram2 pathway in a rat model of traumatic brain injury
Hengchang Li et al.
AGING-US (2020)
The fluorescence toolbox for visualizing autophagy
Siyang Ding et al.
CHEMICAL SOCIETY REVIEWS (2020)
Reparative T lymphocytes in organ injury
Franco R. D'Alessio et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Role of JNK Signaling Pathway in Dexmedetomidine Post-Conditioning-Induced Reduction of the Inflammatory Response and Autophagy Effect of Focal Cerebral Ischemia Reperfusion Injury in Rats
Yulin Zhu et al.
INFLAMMATION (2019)
Dexmedetomidine prevents septic myocardial dysfunction in rats via activation of α7nAChR and PI3K/Akt- mediated autophagy
Tianyi Yu et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Perioperative adverse events attributed to α2-adrenoceptor agonists in patients not at risk of cardiovascular events: systematic review and meta-analysis
Migena Demiri et al.
BRITISH JOURNAL OF ANAESTHESIA (2019)
An overview of microRNAs: Biology, functions, therapeutics, and analysis methods
Kioomars Saliminejad et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Clinical Practice Guidelines for the Prevention and Management of Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU
John W. Devlin et al.
CRITICAL CARE MEDICINE (2018)
Dexmedetomidine protects the developing rat brain against the neurotoxicity wrought by sevoflurane: role of autophagy and Drp1-Bax signaling
Yangyang Shan et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2018)
Di-n-butyl phthalate induced hypospadias relates to autophagy in genital tubercle via the PI3K/Akt/mTOR pathway
Xiang Li et al.
JOURNAL OF OCCUPATIONAL HEALTH (2017)
Effects and mechanisms of compound Chinese medicine and major ingredients on microcirculatory dysfunction and organ injury induced by ischemia/reperfusion
Jing-Yan Han et al.
PHARMACOLOGY & THERAPEUTICS (2017)
Dexmedetomidine Protects Mouse Brain from Ischemia-Reperfusion Injury via Inhibiting Neuronal Autophagy through Up-Regulating HIF-1α
Cong Luo et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2017)
Myocardial protective effects of dexmedetomidine in patients undergoing cardiac surgery: A meta-analysis and systematic review
Zheng Gong et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2017)
Dexmedetomidine preconditioning protects against lung injury induced by ischemia-reperfusion through inhibition of autophagy
Wei Zhang et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2017)
Dexmedetomidine exerts neuroprotective effect via the activation of the PI3K/Akt/mTOR signaling pathway in rats with traumatic brain injury
Min Shen et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Clinical Pharmacokinetics and Pharmacodynamics of Dexmedetomidine
Maud A. S. Weerink et al.
CLINICAL PHARMACOKINETICS (2017)
The Role of Extracellular Adenosine Triphosphate in Ischemic Organ Injury
Hailin Zhao et al.
CRITICAL CARE MEDICINE (2016)
Effects of mild hypoalbuminemia on the pharmacokinetics and pharmacodynamics of dexmedetomidine in patients after major abdominal or thoracic surgery
Ting Zhang et al.
JOURNAL OF CLINICAL ANESTHESIA (2015)
Autophagy activation reduces renal tubular injury induced by urinary proteins
Wei Jing Liu et al.
AUTOPHAGY (2014)
Molecular targets and mechanism of action of dexmedetomidine in treatment of ischemia/reperfusion injury (Review)
Ye Cai et al.
MOLECULAR MEDICINE REPORTS (2014)
Molecularly targeting the PI3K-Akt-mTOR pathway can sensitize cancer cells to radiotherapy and chemotherapy
Ziwen Wang et al.
CELLULAR & MOLECULAR BIOLOGY LETTERS (2014)
Dexmedetomidine preconditioning ameliorates kidney ischemia-reperfusion injury
Juha Lempiainen et al.
PHARMACOLOGY RESEARCH & PERSPECTIVES (2014)
Neuroprotective effect of brain-derived neurotrophic factor mediated by autophagy through the PI3K/Akt/mTOR pathway
Ai Chen et al.
MOLECULAR MEDICINE REPORTS (2013)
Autophagy and the Immune System
Petric Kuballa et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 30 (2012)
Dexmedetomidine in Children: Current Knowledge and Future Applications
Keira P. Mason et al.
ANESTHESIA AND ANALGESIA (2011)
AUTOPHAGY IS INVOLVED IN TRAUMATIC BRAIN INJURY-INDUCED CELL DEATH AND CONTRIBUTES TO FUNCTIONAL OUTCOME DEFICITS IN MICE
C. -L. Luo et al.
NEUROSCIENCE (2011)
Autophagy was activated in injured astrocytes and mildly decreased cell survival following glucose and oxygen deprivation and focal cerebral ischemia
Ai-Ping Qin et al.
AUTOPHAGY (2010)
Research Effect of dexmedetomidine versus lorazepam on outcome in patients with sepsis: an a priori-designed analysis of the MENDS randomized controlled trial
Pratik P. Pandharipande et al.
CRITICAL CARE (2010)
Dexmedetomidine vs Midazolam for Sedation of Critically Ill Patients A Randomized Trial
Richard R. Riker et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Apoptosis meets autophagy-like cell death in the ischemic penumbra:: Two sides of the some coin?
Abdelhaq Rami et al.
AUTOPHAGY (2008)
Dexmedetomidine and cardiac protection for non-cardiac surgery: a meta-analysis of randomised controlled trials
B. M. Biccard et al.
ANAESTHESIA (2008)
Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients - The MENDS randomized controlled trial
Pratik P. Pandharipande et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Functional and physical interaction between Bcl-XL and a BH3-like domain in Beclin-1
M. Chiara Maiuri et al.
EMBO JOURNAL (2007)
The role of postischemic reperfusion injury and other nonantigen-dependent inflammatory pathways in transplantation
WG Land
TRANSPLANTATION (2005)
Dexmedetomidine infusion for more than 24 hours in critically ill patients: sedative and cardiovascular effects
Y Shehabi et al.
INTENSIVE CARE MEDICINE (2004)
Dexmedetomidine pharmacodynamics: Part I - Crossover comparison of the respiratory effects of dexmedetomidine and remifentanil in healthy volunteers
YW Hsu et al.
ANESTHESIOLOGY (2004)
The effects of increasing plasma concentrations of dexmedetomidine in humans
TJ Ebert et al.
ANESTHESIOLOGY (2000)
Share Paper
